Deferoxamine-d7 Trifluoroacetic Acid Salt (Major)

CAS: 162442-10-6

Ref. TR-D228982

Informação sobre produto

• Nome: Deferoxamine-d7 Trifluoroacetic Acid Salt (Major)
• Sinónimos: N1-(5-Aminopentyl)-N1-hydroxy-N4-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]butanediamide-d7 Trifluoroacetic Acid Salt, N-[5-[3-[(5-Aminopentyl)hydroxycarbamoyl]propionamido]pentyl]-3-[[5-(N-hydroxyacetamido)pentyl]carbamoyl]propionohydroxamic Acid-d7 Trifluoroacetic Acid Salt, Ba 33112-d7, DFOM-d7, DFX-d7 Trifluoroacetic Acid Salt, Deferoxamine B-d7 Trifluoroacetic Acid Salt, Deferoxamine-d7 Trifluoroacetic Acid Salt, Deferrioxamine B-d7 Trifluoroacetic Acid Salt, Desferal-d7 Trifluoroacetic Acid Salt, Desferrioxamine B-d7 Trifluoroacetic Acid Salt, Desferrioxamine-d7 Trifluoroacetic Acid Salt
• Marca: TRC

Descrição

Applications Deferoxamine-d7 Trifluoroacetic Acid Salt, is labelled Deferoxamine Trifluoroacetic Acid Salt (D228981), an iron chelating agent used in therapy for patients with sickle cell diseases and iron overload. Studies suggest that it can exert potential antioxidant neuroprotective effects in stroke patients.
References Inati, A. et al.: Am. J. Hematol., 85, 782 (2010); Selim, M.: Translat. Stroke Res., 1, 35 (2010); Cappellini, M.D. et al.: Hemoblobin, 33, 258 (2009)

Propriedades químicas

• Peso molecular: 681.8
• Fórmula: C₂₅D₇H₄₁N₆O₈·x(C₂HF₃O₂)
• Cor/forma: Neat
• InChI: InChI=1S/C25H48N6O8.C2HF3O2/c1-21(32)29(37)18-9-3-6-16-27-22(33)12-14-25(36)31(39)20-10-4-7-17-28-23(34)11-13-24(35)30(38)19-8-2-5-15-26;3-2(4,5)1(6)7/h37-39H,2-20,26H2,1H3,(H,27,33)(H,28,34);(H,6,7)/i1D3,12D2,14D2